Top analysts on stock perps · Analyst
Jason Gerberry (Bank of America Securities): analyst track record on stock perps
Jason Gerberry of Bank of America Securities on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.9★
Success57%
Excess return+16.7%
rank#331
Ratings480
ratings on stock perps168
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 287 | 656 |
| Stock | 59 | 61 |
| Buy / hold / sell | 199 / 55 / 33 | 454 / 121 / 81 |
| Upgrades / downgrades / initiations | 1 / 6 / 1 | 5 / 13 / 7 |
| Price targets hit / missed | 98 / 162 (38%) | 265 / 330 (45%) |
| Avg. return after a rating (TipRanks) | -10.7% | -0.9% |
| Best / worst call | +107.3% / -93.5% | +219.2% / -98.3% |
After buy calls: median 21-day move +3.0% · vs S&P 500 +0.4% (n = 96) · targets hit within a year 55% (n = 38)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $MRK Merck & Co., Inc. | Buy · Maintained | $163 | +12.2% | Oct 25, 2026 |
| $ABBV AbbVie Inc. | Buy · Maintained | $305 | +6.8% | Oct 22, 2026 |
| $LLY Eli Lilly and Company | Buy · Reiterated | $1,397 | +9.7% | Oct 19, 2026 |
| $JNJ Johnson & Johnson | Hold · Maintained | $275 | +4.2% | Oct 14, 2026 |
| $ARWR Arrowhead Pharmaceuticals, Inc. | Buy · Maintained | $100 | +72.4% | Oct 12, 2026 |
| $BMY Bristol Myers Squibb | Buy · Maintained | $66.00 | +7.4% | Oct 9, 2026 |
| $EXEL Exelixis, Inc. | Sell · Maintained | $41.00 | -36.5% | Oct 9, 2026 |
| $PFE Pfizer Inc. | Hold · Maintained | $29.00 | -3.4% | Oct 9, 2026 |
| $PCVX Vaxcyte, Inc. | Buy · Reiterated | $146 | +141.6% | Oct 5, 2026 |
Recent ratings
- Oct 25, 2026 $MRK: Maintained · Buy · $163 · article
- Oct 25, 2026 $MRK: Reiterated · Buy · $163
- Oct 22, 2026 $MRK: Reiterated · Buy · $163 · article
- Oct 22, 2026 $ABBV: Maintained · Buy · $305 · article
- Oct 22, 2026 $ABBV: Maintained · Buy · $305
- Oct 19, 2026 $ABBV: Maintained · Buy · $305 · article
- Oct 19, 2026 $LLY: Reiterated · Buy · $1,397 · article
- Oct 19, 2026 $LLY: Reiterated · Buy · $1,397
- Oct 13, 2026 $JNJ: Reiterated · Hold · $275 · article
- Oct 14, 2026 $JNJ: Maintained · Hold · $275 · article
- Oct 12, 2026 $ARWR: Maintained · Buy · $100 · article
- Oct 9, 2026 $EXEL: Maintained · Sell · $41.00 · article
- Oct 9, 2026 $LLY: Reiterated · Buy · $1,341 · article
- Oct 9, 2026 $JNJ: Maintained · Hold · $282 · article
- Oct 9, 2026 $MRK: Maintained · Buy · $163 · article
- Oct 9, 2026 $PFE: Maintained · Hold · $29.00 · article
- Oct 9, 2026 $JNJ: Maintained · Hold · $282 · article
- Oct 9, 2026 $ABBV: Maintained · Buy · $305 · article
- Oct 9, 2026 $BMY: Maintained · Buy · $66.00 · article
- Oct 9, 2026 $BMY: Maintained · Buy · $66.00 · article
Jason Gerberry4.9★ · 57% success · +16.7% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.